Abstract
A disposable screen-printed sensor has been crafted specifically for therapeutic drug monitoring purposes, particularly for detecting ofloxacin in biological fluids. To enhance selectivity toward ofloxacin, a supramolecular calix [6] arene serves as the ionophore of choice. The sensor incorporates a graphene nanocomposite as an ion-to-electron transducer layer, which not only boosts potential stability but also mitigates potential drift. The developed ofloxacin sensor underwent rigorous characterization following IUPAC guidelines. The linearity range spans from 1 × 10–6 to 1 × 10–2 M, with a measured slope of 59.0 mV/decade. Impressively, it boasts a percentage recovery of 100.18 ± 1.60 and a low detection limit (LOD) of 6 × 10–7 M. Stability assessments indicate reliable performance over an extended period of 8 weeks. The versatility of this sensor extends to various applications, including the determination of ofloxacin in pharmaceutical formulations, bulk powder, and biological fluids. Notably, it has demonstrated efficacy post-bioanalysis validation, adhering to Food and Drug Administration regulations. This advancement holds promise for personalized therapeutic drug monitoring in clinical pharmacy studies and quality control laboratories, thereby optimizing patient care at the point-of-care.
Graphical abstract
Similar content being viewed by others
Introduction
Therapeutic drug monitoring (TDM) plays a crucial role in tailoring medical care to each patient's needs, impacting the prescription regimen significantly (Kang and Lee 2009; Teymourian et al. 2020; Hesham et al. 2024). Its primary objective is to maintain optimal concentrations of challenging medications to improve clinical outcomes across various medical scenarios (Kang and Lee 2009). Particularly for antibiotics, frequent TDM is essential to ensure adequate dosage exposure, mitigate antibiotic resistance, and minimize side effects (Osorio et al. 2021). Inadequate antibiotic concentrations can lead to decreased cure rates and foster the development of bacterial resistance (Ayukekbong et al. 2017; Gad et al. 2021; Kümmerer 2009).
TDM encompasses not only the measurement of drug concentrations in plasma samples but also extends to salivary and urinary samples (Amponsah and Pathak 2022). Utilizing alternative sample sources such as saliva offers a noninvasive collection method, potentially reducing the risks and costs associated with blood-based TDM (Braun et al. 2016; Tsubakihara et al. 1994). While blood sampling remains prevalent, it poses risks such as infection, pain, and local hematoma, particularly problematic in certain demographics like neonates and the elderly (Hutchinson et al. 2018).
Ofloxacin is a potent broad-spectrum antibiotic of the fluoroquinolone class utilized for bacterial infections (Si et al. 2018). Its chemical structure is depicted in Fig. 1. Ofloxacin functions by inhibiting DNA gyrase, topoisomerase type II and IV enzymes crucial for detaching replicated DNA, thereby impeding bacterial cell division (Hussain et al. 2016). Notably, ofloxacin stands out for its dual administration routes, being effective both orally and intravenously, a feature not common among broad-spectrum antibacterial drugs (Todd and Faulds 1991).
Ofloxacin has demonstrated efficacy across various infections, often comparable to standard treatments (Si et al. 2018). In pediatric cases of acute uncomplicated typhoid fever, ofloxacin achieves a serum C max of approximately ~ 24 μM following intravenous injection (Bethell et al. 1996). In the context of “precision medicine,” there is a pressing need to develop sensitive and selective methods, such as point-of-care testing diagnostics (POCT), for accurately determining ofloxacin levels in biological fluids, enabling personalized dosage adjustments. Recent research suggests that monitoring ofloxacin concentrations in saliva is a valid approach, correlating well with blood levels. This method ensures that the drug concentration effectively reaches therapeutic targets, particularly in bronchial secretions (Hutchinson et al. 2018; Kumar and Gurumurthy 2004; Koizumi et al. 1994).
Existing methods for monitoring plasma ofloxacin levels typically rely on blood samples analyzed through immunoassays, high-performance liquid chromatography–mass spectrometry (HPLC–MS) (Attimarad and Alnajjar, 2013), HPLC (Attimarad and Alnajjar, 2013; Immanuel and Kumar 2001), liquid chromatography with tandem mass spectrometry (LC–MS/MS) (Meredith et al. 2012), or dispersive micro solid-phase extraction (DµSPE) (Owaid et al. 2020; Attimarad and Alnajjar, 2013; Meredith et al. 2012; Immanuel and Kumar 2001). However, these methods are laborious, time-consuming, and require fully equipped laboratories, resulting in turnaround times ranging from hours to days. Consequently, TDM of ofloxacin is infrequently conducted, providing limited data points that may not accurately reflect a patient’s metabolism and pharmacokinetics (Zeng et al. 2019; Abdul-Aziz et al. 2020). The slow and cumbersome nature of current drug measurement methods poses a significant barrier to wider TDM adoption, especially in resource-limited settings.
Electrochemical sensing methods have emerged as a prominent tool for detecting various drugs, including ofloxacin, in biological samples owing to their array of benefits: high sensitivity, selectivity, rapid detection, cost-effectiveness, ease of use, portability, and swift response. Ofloxacin has received considerable attention in the development of such methods. Specific electrochemical sensing techniques tailored for detecting ofloxacin in biological samples include voltammetric techniques (Feng et al. 2020), electrochemical impedance spectroscopy (EIS) (Hui and Ying 2017), electrochemical biosensors leveraging enzymes or antibodies for detection (Majdinasab 2017), microfluidic electrochemical devices integrating electrochemical sensors with microfluidic platforms to enhance detection capabilities (Wu et al. 2022), screen-printed electrodes (Liu et al. 2023), and nanostructured electrodes incorporating materials like carbon nanotubes, graphene, and metal nanoparticles to improve sensitivity (Solangi et al. 2022). While these methods hold promise for ofloxacin detection, achieving high specificity for ofloxacin detection in complex samples can be challenging, especially in the presence of structurally similar compounds or matrix effects, necessitating advanced signal processing or multi-parameter analysis approaches. When selecting or designing an electrochemical sensing strategy for ofloxacin detection, it is crucial to weigh these advantages and disadvantages based on specific application requirements and constraints.
Our objective of this study is to establish a platform that facilitates the measurement of plasma, urine, or salivary drug levels as easily and conveniently as existing blood glucose measurements in point-of-care settings (Dauphin-Ducharme et al. 2019). It aims at development of an electrochemical sensor, a reagent-less, single-step sensing platform for rapid, real-time measurement of drug levels in these biological fluids. Electrochemical methods offer several advantages over traditional analytical methods, including simplicity, cost-effectiveness, high sensitivity, easy miniaturization, portability, rapid response, user-friendliness, wide concentration measurement range, low power requirements, and eco-friendliness (Hassan et al. 2020; Mohamed 2016), making them a sustainable option for TDM implementation.
In this work, we fabricated solid-contact ion-selective electrode for selectively determining ofloxacin in spiked biological fluids (plasma, urine, and saliva) and pharmaceutical formulations. Firstly, screening for a selective ionophore to enhance selectivity was performed. Secondly, to enhance sensor performance, graphene nanocomposite has been introduced between the screen-printed carbon electrode and the ion-selective membrane. The effect of graphene integration on the fabricated sensor’s stability and performance was investigated by studying the aqueous layer and potential drift tests. These sensors’ figure of merit was assessed as stated by International Union of Pure and Applied Chemistry (IUPAC) guidelines (Thompson et al. 2006). Finally, the developed sensor has been utilized for determining ofloxacin in its pharmaceutical formulations and in spiked biological fluids with neither previous separation nor sample pretreatment.
Experimental
Instruments
Jenway Model 3330 Digital Ion Analyzer (Essex, UK) with Ag/AgCl with 3 M KCl double-junction reference electrode (Aldrich Chemical Co. Stein Heim, Germany).
Chemicals and materials
Pure ofloxacin powder was kindly provided from SEDICO Pharmaceutical Company, Egypt, with a purity of 100.4% ± 0.8. Ofloxacin tablets were supplied by SEDICO Pharmaceutical Company, Egypt, batch number (18,871/2008), each tablet labeled to contain 200 mg ofloxacin as active ingredient. ORNI-O™ tablets, manufactured by Acme Lite Tech-LLP, India, batch number (ALT19317), each tablet labeled to contain both 200 mg ofloxacin and 500 mg ornidazole as active pharmaceutical ingredients.
High molecular weight polyvinyl chloride (PVC), 2-nitrophenyl octyl ether (o-NPOE), potassium tetrakis(chlorophenyl)borate (K-TpCPB), calix-4-arene (CX4), tetrahydrofuran (THF), 2-hydroxypropyl β-cyclodextrin (2-HP-β-CD), and calix-6-arene (CX6) were purchased from Sigma-Aldrich (Stein Hei, Germany). (Pe)4N Br was obtained from Merck (Darmstadt, Germany). KCl, NaOH, o-H3PO4 solution, xylene, and KH2PO4 and boric acid were purchased from Al-Nasr pharmaceutical chemical company (Cairo, Egypt). Screen-printed carbon electrodes (C-SPE) with a diameter of 3 mm were obtained from CH Instruments Inc., (Texas, USA). Graphene nanoplatelets, with 6–8 nm thickness and 5 microns width, were purchased from Strem Chemicals Inc. (New-bury port, USA).
Standard solutions
Ofloxacin stock standard solution (1 × 10–2 M).
An accurate weight equivalent to 90.4 mg of ofloxacin was transferred to a 25-mL volumetric flask. The volume was then adjusted to achieve a final concentration of (1 × 10–2 M) using Britton–Robinson buffer (BRB), pH 2.9.
Ofloxacin (OFL) working standard solutions
Fresh ofloxacin solutions with varying concentrations (1 × 10–7–1 × 10–3 M) were prepared by serial dilutions from a stock solution using a BRB pH 2.9.
Procedures
Fabricating ofloxacin sensors
Preparation of ion-selective membranes impregnated with various ionophore:
To screen for the ionophore, various sensors were prepared. The ionophore-free membrane (sensor 1a) was composed of 66.6 wt% o-NPOE, 33.17 wt% PVC, and 0.23 wt% K-TpCPB with a total weight (600 mg) was mixed and dissolved in 6.0-mL tetrahydrofuran. Sensor 1b contains CX6 as ionophore, with the membrane composed of 66.6 wt% o-NPOE, 32.54 wt% PVC, 0.23 wt% K-TpCPB, and 0.63 wt% CX6. Sensor 1c contains CX4, with the membrane composed of 66.6 wt% o-NPOE, 32.75 wt% PVC, 0.23 wt% K-TpCPB, and 0.42 wt% CX4. Sensor 1d has 2-HP-β-CD as ionophore, and the membrane composed of 66.6 wt% o-NPOE, 31.85 wt% PVC, 0.23 wt% K-TpCPB, and 1.32 wt% 2-HP-β-CD.
All ionophore-doped membranes contain K-TpCPB and the respective ionophore in a 1:2 molar ratio. K-TpCPB was used to enhance long-term stability of the sensor (Mousavi et al. 2018).
Graphene nanocomposite (GNC) preparation
As previously reported by our group (Mahmoud et al. 2020; Moaaz et al. 2021), 1.0% (w/v), a graphene nanocomposite was prepared using the solution dispersion procedure outlined by Li et al. (2014). In brief, 95.0 mg PVC was dissolved in 3.0-mL THF along with 0.2-mL plasticizer (i.e., o-NPOE). A 10.0-mg portion graphene was dispersed in 1.0-mL xylene using ultrasonication for 5 min. Subsequently, the graphene dispersion was mixed with THF solution and subjected to further ultrasonication for 10 min.
Solid-contact ion-selective sensors assembly
Fabricating control screen-printed (C-SPE/ISM) sensor 2
A 20.0 μL of the optimized ion-selective membrane was cast onto the surface of C-SPE and left to evaporate over night at room temperature.
Preparation of screen-printed/graphene nanocomposite (C-SPE/GNC/ISM) sensor 3
A 10.0 μL of GNC dispersion was applied onto C-SPE and left to evaporate over night at room temperature. The preparation steps were carried out as previously described for the fabrication of C-SPE/ISM (sensor 2).
Conditioning of solid-contact ion-selective electrodes
The fabricated C-SPE sensors were immersed for 24 h in 1 × 10–3 M ofloxacin solution before measurements were conducted.
Evaluation of operative life, response time, and slope of the suggested sensors
The electrochemical performance of proposed sensors was evaluated according to the international union of pure and applied chemistry (IUPAC) guidelines (Thevenot et al. 1996).
Ionophore-doped membranes’ selectivity level
To study the selectivity of the ionophore toward ofloxacin and its ability to decrease the transfer energy of ofloxacin ion into the ion-selective membrane (ISM), we employed the reference ion method commonly used in potentiometry. The potential differences between various ISM potential and reference ion is measured (ΔE = Ei − E (Pe)4N+) in electromotive force (emf). The reference ion chosen for this study was (Pe)4N+. The response of different ionophore-doped membranes to ofloxacin and to the interferent ornidazole (co-formulated with ofloxacin in ORNI-tablets) was noted.
Aqueous layer test and signal drift recording for potential stability testing
The aqueous layer test was conducted by measuring the potential response of both C-SPE sensors (SPE sensors 2 and C-SPE 3) for 3 h. During the first hour, the sensors were immersed in 1 × 10–3 M ofloxacin. Subsequently, for the second hour, the sensors were transferred into 1 × 10–2 M tetrapentylammonium bromide. Finally, in the third hour, the sensors were immersed in 1 × 10–3 M ofloxacin solution. The potential signal drift was observed by recording the emf values.
The effect of pH on the sensor performance
The effect of pH on the response sensor 3 (C-SPE/GNC/ISM(CX6)) was recorded over the pH range of 2–10. The potential measured at each pH value was recorded and plotted as function of pH.
Sensor selectivity study
The separate solutions method (SSM) as described by Zhang et al. (2000) was used to assess the extent to which an extraneous substance may interfere with the determination of ofloxacin using C-SPE/GNC/ISM(CX6), sensor 3. In the appearance of various additives and in the appearance of ornidazole (co-formulated with ofloxacin in ORNI-tablets), the potential response sensor was recorded. The potentiometric selectivity coefficient (log KAB) was calculated according to the following equation:
where E1 is the measured potential of 1.0 × 10–3 M of ofloxacin and E2 is the measured potential of 1.0 × 10–3 M of interfering ion. S is the slope of the involved sensor. ZOFL and ZInt are the charges of ofloxacin (ZOFL = 1) and interfering ion, respectively, and a(OFL) is the drug concentration in terms of activity.
Calibration of sensors
Each sensor was individually paired with double-junction reference electrode and calibrated by immersion in solutions of ofloxacin (1 × 10–7 to 1 × 10–2 M). The solutions were stirred using a magnetic stirrer until a constant emf was obtained. Calibration curves were then plotted between the emf recorded from the suggested sensors against the ofloxacin concentration [− log of [OFL]. Subsequently, the corresponding regression equations were calculated.
Electrochemical determination of ofloxacin in dosage forms
Ten tablets were accurately weighed and grinded into a fine powder. A weight of 0.09 g ofloxacin was transferred into a 25-mL volumetric flask, and BRB pH 2.9 was used to complete the volume. The resultant solution concentration is claimed to be 1 × 10–2 M ofloxacin. From the prepared solution, 2.5 mL was withdrawn and transferred into a 25-mL volumetric flask and again BRB at pH 2.9 was used to complete the volume, resulting in a 1 × 10–3 M ofloxacin solution. In the prepared solution, the screen-printed graphene nanocomposite electrode (C-SPE/GNC/ISM(CX6), sensor 3) was immersed with the Ag/AgCl double-junction reference electrode. The potentials measured from this setup were used to calculate ofloxacin corresponding concentrations from the regression equation of that sensor.
Electrochemical determination of ofloxacin in spiked human biological fluids; (plasma, urine, and saliva)
Preparation of calibrator samples
Human plasma was obtained from holding company for biological products and vaccines (Vacsera) in Cairo, Egypt, urine, and saliva sourced from six different origins. All samples were collected and used in their original state without deprotonation or purification.
Linearities
Calculated aliquots of stock standard solution were transferred to a 10-mL volumetric flask and diluted with borate buffer. The final samples were prepared by mixing 1 ML of each concentrations with 1 mL of biological fluids to obtain the concentration rang of 1 × 10 − 7—1 × 10 − 2. The procedure followed was as described in “Calibration of Sensors” section. To construct the calibration curves, the regression was computed and bioanalysis validation was performed.
Preparation of quality control samples
Quality control (QC) samples consisting of low (QCL), medium (QCM), and high (QCH) concentrations were used. QCL was set at three times the lower limit of quantification (LLOQ). The QCM ranged from 30 to 50% and QCH was 70% of the highest concentration in the range. Into three 10-mL volumetric flasks, 1 mL of ofloxacin-free human biological fluids (plasma, urine, and saliva) was separately introduced in each flask. Subsequently, 1 mL of ofloxacin standard solutions (ranging from 1 × 10–4 to 1 × 10–2 M) was added in each flask. The volumes were completed using BRB pH 2.9 to obtain a final concentration of 1 × 10–5, 1 × 10–4 and 1 × 10–3 M of OFL in each sample. The screen-printed graphene nanocomposite electrode (C-SPE/GNC/ISM (CX6), sensor 3) was used to estimate the ofloxacin concentration in the samples without pretreatment. Ofloxacin concentrations were calculated from the corresponding regression equation.
Results and discussion
Frequent therapeutic drug monitoring (TDM) is essential to ensure that adequate optimal concentrations of the drugs, particularly antibiotics, are maintained throughout the course of treatment. Current methods for monitoring plasma ofloxacin levels, especially in the presence of structurally similar compounds or matrix effects, are time-consuming and demand fully equipped laboratories, resulting in turnaround times ranging from hours to days. Electrochemical sensing methods have emerged as a prominent tool for detecting various drugs, including ofloxacin, in biological samples due to their array of benefits: high sensitivity, selectivity, rapid detection, cost-effectiveness, ease of use, portability, and swift response.
Potentiometric ion-selective electrodes (ISEs) have found extensive application across ecological (De Marco et al. 2007), medical, and biological fields (Ding and Qin 2020; Oesch et al. 1986). These electrodes facilitate the determination of target ion activity in sample solutions by measuring electromotive force at the electrode/sample interface against a reference electrode (Mahmoud et al. 2020). While conventional liquid-contact ISEs were the initial platform, their drawbacks, such as solution evaporation and short lifespan, prompted the development of solid-state ISEs (Burnett et al. 2000; Rius-Ruiz et al. 2011; Wring et al. 1990). Solid-contact ISEs offer advantages such as ease of fabrication, miniaturization, and mass production (Fares et al. 2022). However, they are susceptible to potential drift over time (Ayish et al. 2022; Lyu et al. 2020). To address these issues, hydrophobic ion-to-electron transducer layers, typically positioned between the electrode surface and ion-sensing membrane, have been proposed. Conducting polymers with high oxidation–reduction capacity, such as polyaniline and polypyrrole, have been utilized for this purpose (Vanamo and Bobacka 2014), demonstrating improvements in detection limits and potential drift reduction. However, these polymers are sensitive to factors like light, oxygen, CO2, and sample pH (Li et al. 2012).
Graphene, being a remarkable carbon allotrope, possesses numerous merits that render it highly attractive for various applications, including biosensing. Graphene-based materials have received significant attention in biosensing applications due to their versatility and potential, showcasing remarkable capabilities in enhancing sensitivity, selectivity, and reliability for the detection of biomolecules. As a single-layer carbon allotrope arranged in a 2D lattice structure, it has emerged as a promising material for enhancing the stability and signal of screen-printed electrodes (SPEs) while eliminating unwanted aqueous layers (Hassan et al. 2022; Sharma et al. 2014; Sharma et al. 2013). By integrating graphene into SPEs, improved electrode stability and signal integrity can be achieved, contributing to the advancement of potentiometric ISEs for various applications.
In recent studies, innovative approaches have been explored for the bioanalysis of antibiotics and other biomolecules using advanced materials and techniques. For instance, a photoelectrochemical bioanalysis method based on branched hybridization chain reaction, utilizing rGO–Bi2WO6–Au hybrids, and gold nanoclusters-functionalized MnO2 nanosheets with target-induced etching reaction were developed for the quantitative or qualitative screening of antibiotic residues (Zeng et al. 2018, 2019). Additionally, a signal-on photoelectrochemical sensing system employing reduced graphene oxide/BiFeO3 nanohybrids was developed for the detection of prostate-specific antigen (Zhou et al. 2018). Like the previous methods, this approach sounds complex and time-consuming, requiring precise control over experimental conditions and optimization of assay parameters. The presence of reduced graphene oxide (rGO), bismuth tungstate (Bi2WO6), and gold (Au) or rGO and BiFeO3 suggests a multi-step synthesis process to fabricate the sensing platform, necessitating fully equipped laboratories and considerable time.
Building on these advancements, our work focused on fabricating a solid-contact ion-selective electrode tailored for selectively determining ofloxacin in spiked biological fluids (plasma, urine, and saliva) as well as pharmaceutical formulations. The electrochemical monitoring of ofloxacin depends on the selective binding of the compound to a recognition element immobilized on an electrode surface. Subsequently, this binding event is transduced into a measurable electrochemical signal for quantification. This approach presents several advantages, including high sensitivity, selectivity, and rapid detection, rendering it suitable for diverse applications in pharmaceutical analysis, environmental monitoring, and clinical diagnostics. Initially, we conducted screening to identify a selective ionophore to enhance the sensor’s specificity. Subsequently, to further improve sensor performance, we introduced a graphene nanocomposite between the screen-printed carbon electrode and the ion-selective membrane. The impact of graphene integration on the sensor’s stability and performance was thoroughly investigated through aqueous layer and potential drift tests. The sensors’ figure of merit was assessed in accordance with IUPAC guidelines.
Finally, the developed sensor was applied to the determination of ofloxacin in both pharmaceutical formulations and spiked biological fluids without the need for prior separation or sample pretreatment. This approach represents a promising step toward efficient and convenient ofloxacin monitoring in various clinical and pharmaceutical settings.
Sensing mechanism of ion-selective electrodes (ISEs)
In the fabrication of ion-selective electrodes (ISEs), a high molecular weight PVC matrix serves as a crucial support of the ISEs. Plasticization is essential in this process with specific considerations for the selection of mediator (Ragab et al. 2015). The ratio of the membrane constituents and the choice of plasticizer significantly impact the response of PVC ISEs, as demonstrated by Gupta et al. (2007). Plasticizers play a vital role in adjusting membrane permittivity to achieve maximum sensitivity and selectivity (Gupta et al. 2006). It is imperative to adjust he quantity of plasticizer to minimize membrane electrical unevenness and prevent component leakage into the sample solution as emphasized by Feng and Huang (1997). Several plasticizers including dioctyl phthalate (DOP), dioctyl sebacate (DOS), and o-NPOE have demonstrated optimum results and have thus been selected for further experiments. Moreover, the type of ion exchanger is another key factor in ISEs optimization and fabrication. Ion exchangers are hydrophobic ionic sites that enhance the process of exchanging the ions at the membrane/sample interface, thereby reducing the resistance of ion-selective membrane. By providing abundant ionic sites within the membrane matrix, they contribute significantly to its performance as discussed by Melnikov et al. (2020). These factors collectively play a pivotal role in the successful optimization and fabrication of ISEs for various applications.
Screening ionophores selectivity toward ofloxacin
Supramolecular macrocycles such as cyclodextrins, calixarenes, resorcinarene, cucurbiturils, and pillarenes have been extensively investigated in target drug delivery and analytical chemistry, as well as in optical sensors and water pollution treatment (Hu et al. 2020). Calixarenes, in particular, are widely studied in the realm of supramolecular hosts and molecular recognition (Han et al. 2014). Calixarenes possess basket-shaped electron-rich aromatic cavities of various sizes that can significantly influence both binding strength and selectivity of the host receptors toward the target analyte through cation-π interactions (Georghiou et al. 2005).
Initially, various ISM sensors labeled as Ia, Ib, Ic, and Id were prepared for the screening of the optimum ionophore and ISM cocktail. Selective ionophore screening was made by investigating the effects of three commercially available ionophores on selectivity.
A recent study has investigated the complexation and utilization of calixarene derivative as a drug carrier system for ofloxacin to enhance its bioavailability (Migliore et al. 2021). Therefore, calixarenes 4, 6, and 2-HP-β-CD were incorporated into the sensing membrane as potential ofloxacin candidate ionophores. The potentiometric technique was used to determine the binding constant among the host ion and the guest macromolecule. As reported in the literature, reference ion methods are used to assess the binding degree for organic ions (Ceresa and Pretsch 1999). In this method, a large aquaphobic ion is employed as a reference ion which unable to fit into the supramolecular cavity. Subsequently, the potential differences (ΔE = Ei − E (Pe)4N+) (Mahmoud et al. 2020) among the emf values of the dissimilar ISMs (ionophore-free, or doped with 2-HP-β-CD, CX6, or CX4) in response to ofloxacin and reference ion were calculated (Fig. 2). The CX6-doped membrane exhibited the minimum ΔE (402.1 mV) for ofloxacin compared to the ionophore-free membrane (438 mV). In contrast, the ΔE recorded was 417.2 mV and 423.4 mV for the CX4 and 2-HP-β-CD doped membranes, respectively. The results shown in Fig. 2 support that CX6 has the maximum affinity for ofloxacin which is consistent with the literature. Therefore, Calix [6] arene was adopted as ionophore in the determination of ofloxacin potentiometrically and was used to fabricate two screen-printed electrodes (SPE). The first C-SPE was a control sensor drop-casted only with the CX6-doped membrane (sensor 2) and the second sensor was covered with a transducer layer of nanocomposite graphene dispersion, followed by the ISM (sensor 3).
Potentiometric sensors using CX6-doped membrane
Two SC-ISEs were fabricated and used to determine ofloxacin using a sensing membrane called CX6-doped ion-selective membrane. SP sensor 2 consisted solely of the CX6 membrane without any transducer layer. Sensor 3, denoted as C-SPE/GNC/ISM(CX6), was initially modified with a transducer layer of graphene nanocomposite, followed by the addition of that the CX6 ISM layer. The signal drift was assessed by monitoring the values of emf over time.
In Fig. 3A, C-SPE/GNC/ISM(CX6), sensor 3, showed stability enhancement with only a signal drift of approximately ~ 0.8 mV/h, in contrast to C-SPE/ISM(CX6) sensor 3, which demonstrated a signal drift of around 12 mV/h (Fig. 3B). These results confirm that the incorporation of graphene nanocomposite enhances electrode stability and reduces signal drift. This enhancement is likely attributed to the hydrophobic nature of graphene, which impedes the development of an aqueous layer between the PVC membrane and the carbon electrode. To further asses this theory, aqueous layer test was conducted.
Calibration of sensors and response time
Table 1 presents the results obtained for the response characteristics over an 8-week period for the proposed sensors. The characteristic calibration graphs are illustrated in Fig. 4. The slope is calculated from the linear portion of the calibration curve. The slopes of the solid-contact electrodes’ calibration graphs are 53.3 and 59.0 mV/decade for the C-SPE/ISM(CX6), sensor 2 and the C-SPE/GNC/ISM(CX6), sensor 3, respectively. The time required for the sensors to reach stable potentiometric readings after increasing the drug concentration by 10 times was found to be 8 s for the C-SPE/ISM(CX6), sensor 2 and close to 2 s for the C-SPE/GNC/ISM(CX6), sensor 3. The C-SPE/ISM(CX6), sensor 2, remains stable over four weeks, while the C-SPE/GNC/ISM(CX6), sensor 3, remains stable and accurate for eight weeks.
Aqueous layer test and signal drift detection for the SPEs
In the aqueous layer test (Hambly et al. 2020), initially, potential readings were recorded from a 1 × 10–3 M ofloxacin solution. Subsequently, measurements were taken upon introducing a solution of a cationic hydrophobic compound (tetrapentylammonium bromide) at a concentration of 1 × 10–3 M. An increase in potential was observed. This increase can be attributed to the replacement of ofloxacin with tetrapentylammonium bromide in the ISM. The final step involved replacing the test solution with the initially used 1 × 10–3 M ofloxacin solution. Interestingly, there was nearly no drift in potential when using C-SPE/GNC/ISM(CX6), sensor 3, compared to C-SPE/ISM(CX6), sensor 2, which exhibited significant potential drift (Fig. 5). This suggests that a GNC layer in sensor 3 prevents water layer formation due to its hydrophobic film effect.
Therefore, the selected electrode for all the measurements was the C-SPE/GNC/ISM(CX6), sensor 3. Consequently, it was applied for determination of ofloxacin in both dosage forms and spiked human fluids.
Effect of pH on sensor characteristics
The pH effect on the response of C-SPE/GNC/ISM(CX6), sensor 3, was investigated (Fig. 6) using 1 × 10–3 and 1 × 10–4 M OFL across a pH range of 2.0–10.0. It is clear that the sensor’s potential response remains quite stable within the pH range 2.0–5.0 where the ofloxacin is completely ionized and can be effectively detected by the ISM.
Selectivity of the sensors
The response of C-SPE/GNC/ISM(CX6), sensor 3, in the presence of ornidazole (co-formulated drug with ofloxacin in ORNI-tablets), excipients of tablets, and both inorganic and organic related ingredients, was evaluated using the separate solutions method. The selectivity coefficients calculated from obtained results confirm a high selectivity toward ofloxacin from the proposed sensor, with minimal interference from the studied interfering substances, as shown in Table 2 and Fig. 7A, B.
Electrochemical determination of ofloxacin in spiked biological fluids
The sensor was utilized to detect ofloxacin in various biological fluids. All samples were collected and used in their original state without deprotonation or purification. The sampling collection of biological fluids, construction of linearity, calculation of lower limit of quantification (LLOQ), and validation parameters were conducted in accordance with relevant FDA (FDA 2018) guidelines to ensure compliance and accuracy in the analysis process.
Bio-analysis validation (linearity, lower limit of quantification (LLOQ))
For linearity and determination of the LLOQ, a calibration curve of the drug in biological fluids was constructed. Triplicates of three concentrations were analyzed using the developed method and the obtained potential was plotted against the corresponding concentration (Fig. 8). LLOQ represents the lowest concentration that can be quantified based on the calibration curve. The acceptable range for accuracy is 80–120%, or %R is ± 15%. For precision, the percentage relative standard deviation (% RSD) should not exceed 15% except for the LLOQ, where it can be ± 20%. (Table 3).
In evaluating accuracy and precision, triplicates of each quality control (QC) sample were utilized.
-
Accuracy defined as the degree of closeness of the results to the true value. It was assessed within run and between run using the percentage recovery (%R).
$$\% R = \left( {{\text{Found}}\;{\text{concentration}}/{\text{Theoretical}}\;{\text{concentration}}} \right) \times 100.$$ -
Precision measures the closeness of the results to each other within-run and between-run precision were evaluated as:
$$\% {\text{RSD}} = {\text{SD}}/{\text{Mean}} \times \, 100$$ -
Selectivity is crucial for ensuring the method's ability to accurately analyze and quantify drugs without interference from substances present in the biological matrix. To evaluate selectivity, blank samples from six different sources are used, with the requirement that the response of interfering substances should not exceed 20% of the response of the analytes at the LLOQ level.
Preparation of quality control samples
Quality control samples include low (QCL), which is three times the LLOQ, medium (QCM), which is 30–50% of the highest concentration in the range, and high (QCH), which is 70% of the highest concentration in the range. The quality control samples were prepared by the same procedure as the calibrators samples. Spiked samples were measured using the method, and concentrations were calculated using the corresponding regression equation. The detection of ofloxacin in saliva and urine is considered a noninvasive alternative to blood tests. The summarized results in Table 3 demonstrate the promising capabilities of the C-SPE/GNC/ISM(CX6) sensor 3 for measuring ofloxacin in biological fluids. These results highlight its potential for future clinical and therapeutic drug monitoring (TDM) studies.
Electrochemical determination of OFL in pharmaceutical formulation
Using the C-SPE/GNC/ISM(CX6), sensor 3, the concentration of ofloxacin in tablets was determined. The mean of three determinations showed precise and accurate recoveries of 100.2% ± 1.6 for ofloxacin in single form and 100.3% ± 1.4 for ofloxacin in binary form. This demonstrates the sensor’s ability for the detection of ofloxacin in pharmaceutical dosage forms without the need for a pretreatment procedures or extraction processes, and without the interference of the co-formulated drug ornidazole. It is noteworthy that our sensor was compared with the potentiometric method in the US pharmacopeia, as presented in Table 4.
The results obtained from C-SPE/GNC/ISM(CX6), sensor 3, were compared to the results obtained using the official potentiometric method to determine the ofloxacin pure sample. No significant difference was found in the results concerning precision and accuracy (Table 4).
Conclusion
In this study, we developed an ion-selective electrode (ISE) based on a solid-contact screen-printed electrode for the detection of ofloxacin in biological fluids for therapeutic drug monitoring and its determination in pharmaceutical formulations. We incorporated a “Nanocomposite Graphene” interlayer as a solid-contact ion-to-electron transducer. The integration of graphene nanocomposite led to improvements in both potential stability and minimized signal drifting, while also reducing the formation of an aqueous layer at the interfacial boundaries between the ion-sensing membrane and carbon screen-printed electrode. Consequently, this enhancement resulted in significant sensor stability compared to control ISEs lacking the transducer. The careful selection of the ionophore CX6 played a pivotal role in improving the selective sensing of ofloxacin with appropriate precision and accuracy. Overall, our work demonstrates the effectiveness of utilizing solid-contact screen-printed electrodes with graphene nanocomposite interlayers for enhanced stability and selective detection of ofloxacin, paving the way for its application in therapeutic drug monitoring and pharmaceutical quality control. The proposed screen-printed solid-contact potentiometric sensor was characterized according to IUPAC guidelines, revealing a slope of 59.0 mV/decade. It exhibited a linear range spanning from 1 × 10–6 to 1 × 10–2 M, with a limit of detection (LOD) of 6 × 10–7 M. The fabricated ofloxacin sensor thus offers a valuable tool for its detection using a selective, sensitive, and disposable potentiometric strip, making it suitable for a range of applications, including the development of selective, sensitive, and disposable potentiometric strips. Manufactured ofloxacin sensors represent a promising tool for everyday sensing applications, eliminating the need for multiple pretreatment processes, hazardous solvents, or costly equipment. This technique is nondestructive and does not consume the analyte during analysis. Moreover, it offers non-contaminating results with a short response time, typically in seconds to minutes. Importantly, the method remains unaffected by sample turbidity or color. Compared to liquid sensors, the setup of ofloxacin sensors is straightforward, making them easy to operate and apply. They offer stability, sustainability, and economic benefits, being eco-friendly with no requirement for solvents or expensive materials. These characteristics collectively make ofloxacin sensors a practical and efficient choice for various sensing applications.
Availability of data and materials
All data and materials generated or analyzed during this study are included in this published article.
References
Abdul-Aziz MH, Alffenaar JWC, Bassetti M, Bracht H, Dimopoulos G, Marriott D, et al. Antimicrobial therapeutic drug monitoring in critically ill adult patients: a Position Paper#. Intensive Care Med. 2020;46(6):1127–53. https://doi.org/10.1007/s00134-020-06050-1.
Amponsah SK, Pathak YV. Therapeutic and toxic concentrations of drugs in biological matrices. In: Amponsah, SK, Pathak YV editors. Recent advances therapeutic drug monitoring and clinical toxicology; 2022. https://doi.org/10.1007/978-3-031-12398-6_1.
Attimarad M, Alnajjar A. A conventional HPLC-MS method for the simultaneous determination of ofloxacin and cefixime in plasma: development and validation. J Basic Clin Pharm. 2013;4(2):36–41. https://doi.org/10.4103/0976-0105.113606.
Ayish NS, Mahmoud AM, Fayed AS, El-Zeany BA, Marzouk HM. A portable solid-state electrochemical sensor based on N-doped graphite as a transducer layer for determination of a multiple sclerosis managing medication in biological fluids. J Solid State Electrochem. 2022;26(3):843–53. https://doi.org/10.1007/s10008-022-05123-z.
Ayukekbong JA, Ntemgwa M, Atabe AN. The threat of antimicrobial resistance in developing countries: causes and control strategies. Antimicrob Resist Infect Control. 2017;6:47. https://doi.org/10.1186/s13756-017-0208-x.
Bethell DB, Day NPJ, Dung NM, Mcmullin C, Loan HT, Tam DTH, et al. Pharmacokinetics of oral and intravenous ofloxacin in children with multidrug-resistant typhoid fever. Antimicrob Agents Chemother. 1996;40(9):2167–72. https://doi.org/10.1128/AAC.40.9.2167.
Braun D, Stegmann B, Haen E. TDM of psychotropic drugs in body fluids. Pharmacopsychiatry. 2016. https://doi.org/10.1055/s-0036-1582045.
Burnett RW, Covington AK, Fogh-Andersen N, Külpmann WR, Lewenstam A, Maas AHJ, et al. Use of ion-selective electrodes for blood-electrolyte analysis. Recommendations for nomenclature, definitions and conventions. Clin Chem Lab Med. 2000;38(4):363–70. https://doi.org/10.1515/CCLM.2000.052.
Ceresa A, Pretsch E. Determination of formal complex formation constants of various Pb2+ ionophores in the sensor membrane phase. Anal Chim Acta. 1999;395(1–2):41–52. https://doi.org/10.1016/S0003-2670(99)00311-6.
Dauphin-Ducharme P, Yang K, Arroyo-Currás N, Ploense KL, Zhang Y, Gerson J, et al. Electrochemical aptamer-based sensors for improved therapeutic drug monitoring and high-precision, feedback-controlled drug delivery. ACS Sens. 2019;4(10):2832–7. https://doi.org/10.1021/acssensors.9b01616.
De Marco R, Clarke G, Pejcic B. Ion-selective electrode potentiometry in environmental analysis. Electroanalysis. 2007;19:1987–2001. https://doi.org/10.1002/elan.200703916.
Ding J, Qin W. Recent advances in potentiometric biosensors. TrAC Trends Anal Chem. 2020;124:115803. https://doi.org/10.1016/j.coelec.2021.100735.
Fares MY, Abdelwahab NS, Hegazy MA, Abdelrahman MM, Mahmoud AM, El-Sayed GM. Nanoparticle-enhanced in-line potentiometric ion sensor for point-of-care diagnostics for tropicamide abuse in biological fluid. Anal Chim Acta. 2022;1192:339350. https://doi.org/10.1016/j.aca.2021.339350
FDA Center for Drug Evaluation and Research (CDER). Bioanalytical Method Validation Guidance for Industry; 2018,1-44.
Feng X, Huang RYM. Liquid separation by membrane pervaporation: a review. Ind Eng Chem Res. 1997;36(4):1048–66. https://doi.org/10.1021/ie960189g.
Feng L, Xue Q, Liu F, et al. Voltammetric determination of ofloxacin by using a laser-modified carbon glassy electrode. Microchim Acta. 2020;187(1):86. https://doi.org/10.1007/s00604-019-4065-6.
Gad AG, Fayez YM, Kelani KM, Mahmoud AM. TLC-smartphone in antibiotics determination and low-quality pharmaceuticals detection. RSC Adv. 2021;11(31):19196–202. https://doi.org/10.1039/d1ra01346g.
Georghiou PE, Li Z, Ashram M, Chowdhury S, Mizyed S, Tran AH, et al. Calixnaphthalenes: deep, electron-rich naphthalene ring-containing calixarenes. The first decade. Synlett. 2005;6:879–91. https://doi.org/10.1002/chin.200531225.
Gupta VK, Singh AK, Mehtab S, Gupta B. A cobalt(II)-selective PVC membrane based on a Schiff base complex of N, N′-bis(salicylidene)-3,4-diaminotoluene. Anal Chim Acta. 2006;566(1):5–10. https://doi.org/10.1016/j.aca.2006.02.038.
Gupta VK, Singh AK, Al Khayat M, Gupta B. Neutral carriers based polymeric membrane electrodes for selective determination of mercury(II). Anal Chim Acta. 2007;590(1):81–90. https://doi.org/10.1016/j.aca.2007.03.014.
Hambly B, Guzinski M, Pendley B, Lindner E. Evaluation, Pitfalls and Recommendations for the “Water Layer Test” for solid contact ion-selective electrodes. Electroanalysis. 2020;32(4):781–91. https://doi.org/10.1002/elan.201900637.
Han Y, Meng Z, Ma YX, Chen CF. Iptycene-derived crown ether hosts for molecular recognition and self-assembly. Acc Chem Res. 2014;47(7):2026–40. https://doi.org/10.1021/ar5000677.
Hassan SA, ElDin NB, Zaazaa HE, Moustafa AA, Mahmoud AM. Point-of-care diagnostics for drugs of abuse in biological fluids: application of a microfabricated disposable copper potentiometric sensor. Microchim Acta. 2020;187(9):491. https://doi.org/10.1007/s00604-020-04445-x.
Hassan SA, Nashat NW, Elghobashy MR, Abbas SS, Moustafa AA, Mahmoud AM. Novel microfabricated solid-contact potentiometric sensors doped with multiwall carbon-nanotubes for simultaneous determination of bisoprolol and perindopril in spiked human plasma. Microchem J. 2022;178:107323. https://doi.org/10.1016/j.microc.2022.107323.
Hesham N, Hegazy MA, Wagdy HA, et al. Therapeutic drug monitoring of six contraindicated/co-administered drugs by simple and green RP-HPLC-PDA; application to spiked human plasma. BMC Chem. 2024;18(1):66. https://doi.org/10.1186/s13065-024-01161-y.
Hu XY, Gao J, Chen FY, Guo DS. A host-guest drug delivery nanosystem for supramolecular chemotherapy. J Control Release. 2020;324:124–33. https://doi.org/10.1016/j.jconrel.2020.05.008.
Hui G, Ying Y. Quantitative rapid analysis method for ofloxacin in raw milk based on molecule-specific recognition and electrochemical impedance spectrum. Trans ASABE. 2017;60(5):1439–43. https://doi.org/10.13031/trans.11465.
Hussain MI, Sarker A, Begum T, Hasin F, Binte Farid Himu F, Riazul Haque Shahin M. Comparative dissolution study of levofloxacin tablets. Quest J J Res Pharm Sci. 2016;3:6–9. ISSN:2347-2995.
Hutchinson L, Sinclair M, Reid B, Burnett K, Callan B. A descriptive systematic review of salivary therapeutic drug monitoring in neonates and infants. Br J Clin Pharmacol. 2018;84(6):1089–108. https://doi.org/10.1111/bcp.13553.
Immanuel C, Kumar AKH. Simple and rapid high-performance liquid chromatography method for the determination of ofloxacin concentrations in plasma and urine. J Chromatogr B Biomed Sci Appl. 2001;760(1):91–5. https://doi.org/10.1016/s0378-4347(01)00260-2.
Kang J-S, Lee M-H. Overview of therapeutic drug monitoring. Korean J Intern Med. 2009;24(1):1–10. https://doi.org/10.3904/kjim.2009.24.1.1.
Koizumi F, Ohnishi A, Takemura H, Okubo S, Kagami T, Tanaka T. Effective monitoring of concentrations of ofloxacin in saliva of patients with chronic respiratory tract infections. Antimicrob Agents Chemother. 1994;38(5):1140–3. https://doi.org/10.1128/AAC.38.5.1140.
Kumar AKH, Gurumurthy P. Ofloxacin pharmacokinetics in saliva. Indian J Pharmacol. 2004;36(2):80–3.
Kümmerer K. Antibiotics in the aquatic environment—a review—Part II. Chemosphere. 2009;75:435–41. https://doi.org/10.1016/j.chemosphere.2008.12.006.
Li F, Ye J, Zhou M, Gan S, Zhang Q, Han D, et al. All-solid-state potassium-selective electrode using graphene as the solid contact. Analyst. 2012;137(3):618–23. https://doi.org/10.1039/C1AN15705A.
Li X, Xiao Y, Bergeret A, Longerey M, Che J. Preparation of polylactide/graphene composites from liquid-phase exfoliated graphite sheets. Polym Compos. 2014;35(2):396–403. https://doi.org/10.1002/pc.22673.
Liu QW, Xue Q, Chang C, Wang R, Liu Y, Xie H. Highly efficient detection of ofloxacin in water by samarium oxide and β-cyclodextrin-modified laser-induced graphene electrode. Microchem J. 2022;186:108353. https://doi.org/10.1016/j.microc.2022.108353.
Lyu Y, Gan S, Bao Y, Zhong L, Xu J, Wang W, et al. Solid-contact ion-selective electrodes: response mechanisms, transducer materials and wearable sensors. Membranes. 2020;10(6):1–24. https://doi.org/10.3390/membranes10060128.
Mahmoud AM, Ragab MT, Ramadan NK, El-Ragehy NA, El-Zeany BA. Design of Solid-contact Ion-selective electrode with graphene transducer layer for the determination of flavoxate hydrochloride in dosage form and in spiked human plasma. Electroanalysis. 2020;32(12):2803–11. https://doi.org/10.1002/elan.202060377.
Majdinasab M. An overview on recent progress in electrochemical biosensors for antimicrobial drug residues in animal-derived food. Sensors. 2017;17(9):1947. https://doi.org/10.3390/s17091947.
Melnikov S, Zabolotskiy V, Bondarev D, Nosova E, Melnikova E. Water splitting and transport of ions in electromembrane system with bilayer ion-exchange membrane. Membranes. 2020;10(11):1–37. https://doi.org/10.3390/membranes10110346.
Meredith SA, Smith PJ, Norman J, Wiesner L. An LC-MS/MS method for the determination of ofloxacin in 20 μl human plasma. J Pharm Biomed Anal. 2012;58(1):177–81. https://doi.org/10.1016/j.jpba.2011.09.030.
Migliore R, Granata G, Rivoli A, Consoli GML, Sgarlata C. Binding affinity and driving forces for the interaction of calixarene-based micellar aggregates with model antibiotics in neutral aqueous solution. Front Chem. 2021;14(8):626467. https://doi.org/10.3389/fchem.
Moaaz EM, Mahmoud AM, Fayed AS, Rezk MR, Abdel-Moety EM. Determination of tedizolid phosphate using graphene nanocomposite based solid contact ion selective electrode; green profile assessment by eco-scale and GAPI approach. Electroanalysis. 2021;33(8):1895–901. https://doi.org/10.1002/elan.202100067.
Mohamed HM. Screen-printed disposable electrodes: pharmaceutical applications and recent developments. TrAC Trends Anal Chem. 2016;82(4):1–11. https://doi.org/10.1016/j.trac.2016.02.010.
Mousavi MPS, Abd El-Rahman MK, Mahmoud AM, Abdelsalam RM, Bühlmann P. In situ sensing of the neurotransmitter acetylcholine in a dynamic range of 1 nM to 1 mM. ACS Sens. 2018;3(12):2581–9. https://doi.org/10.1021/acssensors.8b00950.
Oesch U, Ammann D, Simon W. Ion-selective membrane electrodes for clinical use. Clin Chem. 1986;32:1448–59 PMID: 3524901.
Osorio C, Garzón L, Jaimes D, Silva E, Bustos RH. Impact on antibiotic resistance, therapeutic success, and control of side effects in therapeutic drug monitoring (Tdm) of daptomycin: a scoping review. Antibiotics. 2021;10(3):263. https://doi.org/10.3390/antibiotics10030263.
Owaid SJ, Yahaya N, Rahim NY, Mohammad RAE, Jajuli MN, Miskam M. Development of dispersive micro-solid phase extraction for the analysis of ofloxacin and sparfloxacin in human plasma. Malays J Anal Sci. 2020;24(6):893–905. ISSN 1394-2506.
Ragab MT, Abd El-Rahman MK, Ramadan NK, El-Ragehy NA, El-Zeany BA. Novel potentiometric application for the determination of pantoprazole sodium and itopride hydrochloride in their pure and combined dosage form. Talanta. 2015;138:28–35. https://doi.org/10.1016/j.talanta.2015.01.045.
Rius-Ruiz FX, Crespo GA, Bejarano-Nosas D, Blondeau P, Riu J, Rius FX. Potentiometric strip cell based on carbon nanotubes as transducer layer: toward low-cost decentralized measurements. Anal Chem. 2011;83(22):8810–5. https://doi.org/10.1021/ac202070r.
Sharma P, Tuteja SK, Bhalla V, Shekhawat G, Dravid VP, Suri CR. Bio-functionalized graphene–graphene oxide nanocomposite based electrochemical immunosensing. Biosens Bioelectron. 2013;39(1):99–105. https://doi.org/10.1016/j.bios.2012.06.061.
Sharma BR, Manjanath A, Singh AK. Pentahexoctite: a new two-dimensional allotrope of carbon. Sci Rep. 2014;4:7164. https://doi.org/10.1038/srep07164.
Si X, Wei Y, Wang C, Li L, Ding Y. A sensitive electrochemical sensor for ofloxacin based on a graphene/zinc oxide composite film. Anal Methods. 2018;10:1961. https://doi.org/10.1039/C8AY00127H.
Solangi N, Kumar J, Naz G, Soomro RA. The preparation of NiCo2O4 nanoboulders and their application in the electrochemical detection of ofloxacin drug. JCIS Open. 2022;6:100054. https://doi.org/10.1016/j.jciso.2022.100054.
Teymourian H, Parrilla M, Sempionatto JR, Montiel NF, Barfidokht A, Van Echelpoel R, et al. Wearable electrochemical sensors for the monitoring and screening of drugs. ACS Sens. 2020;5:2679–700. https://doi.org/10.1021/acssensors.0c01318.
Thevenot DR, Toth K, Durst RA, Wilson GS. International union of pure and applied chemistry physical chemistry division, steering committee on biophysical chemistry analytical chemistry division, commission vol 5 (electroanalytical chemistry) Electrochemical biosensors: proposed definitions and cla. Sens Actuators B Chem. 1996;30(1):81.
Thompson M, Ellison SLR, Wood R. The International Harmonized Protocol for the proficiency testing of analytical chemistry laboratories (IUPAC Technical Report). Pure Appl Chem. 2006;78(1):145–96. https://doi.org/10.1351/pac200678010145.
Todd PA, Faulds D. Ofloxacin: a reappraisal of its antimicrobial activity. Pharmacol Ther Use Drugs. 1991;42(5):825–76. https://doi.org/10.2165/00003495-199142050-00008.
Tsubakihara Y, Terumasa H, Tatsuya S, Kitamura E, Okada N, Nakanishi I. Pharmacokinetic study of Ofloxacin using saliva concentration in chronic renal failure. Jpn J Nephrol. 1994;36(3):246–9. PMID: 8196221.
USP NF 21. The United States pharmacopeia—The National Formulary. United States Pharmacopeial Convention, Rockville; 2003.
Vanamo U, Bobacka J. Electrochemical control of the standard potential of solid-contact ion-selective electrodes having a conducting polymer as ion-to-electron transducer. Electrochim Acta. 2014;122:316–21. https://doi.org/10.1016/j.electacta.2013.10.134.
Wring SA, Hart JP, Bracey L, Birch BJ. Development of screen-printed carbon electrodes, chemically modified with cobalt phthalocyanine, for electrochemical sensor applications. Anal Chim Acta. 1990;231(C):203–12. https://doi.org/10.1016/S0003-2670(00)86418-1.
Wu T, Du Y, Dai L, Li J, Song X, et al. A direct Z-scheme AgBr/CuBi2O4 photocathode for ultrasensitive detection of ciprofloxacin and ofloxacin by controlling the release of luminol in self-powered microfluidic photoelectrochemical aptasensors. Anal Chem. 2022;94(30):10651–8. https://doi.org/10.1021/acs.analchem.2c00889.
Zeng R, Su L, Luo Z, Zhang L, Lu M, Tang D. Ultrasensitive and label-free electrochemical aptasensor of kanamycin coupling with hybridization chain reaction and strand-displacement amplification. Anal Chim Acta. 2018;1038:21–8. https://doi.org/10.1016/j.aca.2018.07.010.
Zeng R, Zhang L, Su L, Luo Z, Zhou Q, Tang D. Photoelectrochemical bioanalysis of antibiotics on rGO-Bi2WO6-Au based on branched hybridization chain reaction. Biosens Bioelectron. 2019;133:100–6. https://doi.org/10.1016/j.bios.2019.02.067.
Zhang XB, Guo CC, Jian LX, Shen GL, Yu RQ. Bismetalloporphyrin-based ISE sensitive to fluoroborate. Analyst. 2000;125(12):2285–8. https://doi.org/10.1039/B004125O.
Zhou Q, Lin Y, Zhang K, Li M, Tang D. Reduced graphene oxide/BiFeO3 nanohybrids-based signal-on photoelectrochemical sensing system for prostate-specific antigen detection coupling with magnetic microfluidic device. Biosens Bioelectron. 2018;15(101):146–52. https://doi.org/10.1016/j.bios.2017.10.027.
Acknowledgements
Not applicable.
Funding
No funding was received for this work.
Author information
Authors and Affiliations
Contributions
KMK was involved in conceptualization, supervision, study planning, review, and editing. AMM helped in research idea, supervision manuscript, methodology, data analysis, writing, review, and editing. YMF contributed to support and supervision. AGG conducted the laboratory work, data curation and presentation, and manuscript first draft writing. All authors read and approved the final manuscript.
Corresponding authors
Ethics declarations
Ethics approval and consent to participate
Not applicable.
Competing interests
The authors declare no conflicts of interest relevant to this article.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Kelani, K.M., Fayez, Y.M., Gad, A.G. et al. Design of point-of-care electrochemical sensor for therapeutic drug monitoring of ofloxacin in biological fluids. J Anal Sci Technol 15, 41 (2024). https://doi.org/10.1186/s40543-024-00450-4
Received:
Accepted:
Published:
DOI: https://doi.org/10.1186/s40543-024-00450-4